Article
Rapid Generation of Neutralizing Antibody Responses in COVID-19 Patients

https://doi.org/10.1016/j.xcrm.2020.100040Get rights and content
Under a Creative Commons license
open access

HIGHLIGHTS

  • Cross-sectional study of 44 hospitalized COVID-19 patients

  • RBD-specific IgG responses detectable in all patients 6 days after PCR confirmation

  • Neutralizing titers are detectable in all patients 6 days after PCR confirmation

  • RBD-specific IgG titers correlate with the neutralizing potency

Summary

SARS-CoV-2, the virus responsible for COVID-19, is causing a devastating worldwide pandemic, and there is a pressing need to understand the development, specificity, and neutralizing potency of humoral immune responses during acute infection. We report a cross-sectional study of antibody responses to the receptor-binding domain (RBD) of the spike protein and virus neutralization activity in a cohort of 44 hospitalized COVID-19 patients. RBD-specific IgG responses are detectable in all patients 6 days after PCR confirmation. Isotype switching to IgG occurs rapidly, primarily to IgG1 and IgG3. Using a clinical SARS-CoV-2 isolate, neutralizing antibody titers are detectable in all patients by 6 days after PCR confirmation and correlate with RBD-specific binding IgG titers. The RBD-specific binding data were further validated in a clinical setting with 231 PCR-confirmed COVID-19 patient samples. These findings have implications for understanding protective immunity against SARS-CoV-2, therapeutic use of immune plasma, and development of much-needed vaccines.

Keywords

COVID-19
SARS-CoV-2
neutralizing antibody
spike protein
receptor-binding protein
coronavirus
protective immunity
serology test
humoral immune response

Cited by (0)

11

These authors contributed equally

12

Lead Contact